Haematopoietic stem cell transplantation for patients with chronic myeloid leukaemia after failure of tyrosine kinase inhibitor therapy

被引：0
作者：
Prayongratana, K.
Forrest, D.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S428 / S429
页数：2
相关论文
共 50 条
  • [21] Response to Tyrosine Kinase Inhibitor Therapy In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Phase Chronic Myeloid Leukemia
    Holroyd, Ailsa
    Phillips, Elizabeth
    Szydlo, Richard
    Marin, David
    Foroni, Letizia
    Khorashad, Jamshid
    Milojkovic, Dragana
    Kanfer, Edward J.
    Dazzi, Francesco
    MacDonald, Donald H.
    Rahemtulla, Amin
    McLornan, Donal
    Gabriel, Ian H.
    Pavlu, Jiri
    Sargent, Jeremy
    Goldman, John M.
    Apperley, Jane F.
    Rezvani, Katayoun
    BLOOD, 2010, 116 (21) : 1445 - 1445
  • [22] How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapy
    Rea, Delphine
    Mahon, Francois-Xavier
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (01) : 24 - 32
  • [23] Allogeneic haematopoietic stem cell transplantation for patients with chronic lymphocytic leukaemia
    Zaucha, J. M.
    Bieniaszewska, M.
    Piekarska, A.
    Prejzner, W.
    Knopinska-Posluszny, W.
    Hellmann, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S316 - S316
  • [24] Allogeneic myeloablative haematopoietic stem cell transplantation for chronic myeloid leukaemia in the imatinib era
    Pavlu, J.
    Auner, H.
    Szydlo, R.
    Olavarria, E.
    Giles, C.
    Klammer, M.
    Kew, A.
    Milojkovic, D.
    Gabriel, I.
    Rezvani, K.
    Dazzi, F.
    Marin, D.
    Goldman, J.
    Apperley, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S49 - S49
  • [25] Outcome of allogeneic stem cell transplantation in patients with chronic myeloid leukaemia treated with second generation tyrosine kinases inhibitors after imatinib failure
    Palandri, F.
    Breccia, M.
    Iori, A. P.
    Bonifazi, F.
    Latagliata, R.
    Colaci, E.
    Torelli, G. F.
    Castagnetti, F.
    Valle, V.
    Usai, S.
    Martinelli, G.
    Dell'Agnola, C.
    Cingarlini, S.
    Rosti, G.
    Baccarani, M.
    Alimena, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S261 - S261
  • [26] Allogeneic stem cell transplantation in treatment of chronic myeloid leukaemia - current approach in tyrosine kinase inhibitors era
    Gil, Lidia
    Lewandowski, Krzysztof
    Komarnicki, Mieczyslaw
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2010, 14 (01): : 31 - 38
  • [27] The impact of second generation tyrosine kinase inhibitors on the outcome of allogeneic stem cell transplantation for chronic myeloid leukaemia
    Latif, A.
    Parker, A.
    McQuaker, G.
    Clark, A.
    Copland, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 23 - 24
  • [28] Use of second generation tyrosine kinase inhibitors prior to allogeneic stem cell transplantation in chronic myeloid leukaemia
    Olavarria, E.
    Schleuning, M.
    Chalandon, Y.
    Onida, F.
    Radujkovic, A.
    Robin, M.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S35 - S36
  • [29] Extramedullary relapse of acute myeloid leukaemia after allogeneic haematopoietic stem cell transplantation
    Moreira, C.
    Branca, R.
    Campilho, F.
    Pinho Vaz, C.
    Rosales, M.
    Roncon, S.
    Campos, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S257 - S257
  • [30] The quality of molecular remission after stem cell transplantation in patients with chronic myeloid leukaemia
    Lewandowski, K.
    Gil, L.
    Baranska, M.
    Iwola, M.
    Drozdowska, D.
    Lewandowska, M.
    Komarnicki, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S317 - S317
12345